Advertisement
Screener

NeuroSense Therapeutics Ltd. (NRSN) Description Of Risk Free Interest Rate Share Options Granted

NeuroSense Therapeutics Ltd. Description Of Risk Free Interest Rate Share Options Granted

NeuroSense Therapeutics Ltd. (NRSN) reported Description Of Risk Free Interest Rate Share Options Granted of 4.17% for the 6-month period ending 2023-06-30, per its 6-K filed 2023-08-16.

Discontinued › Notes

ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted · last filed 2023-08-16

Period endDescription Of Risk Free Interest Rate Share Options Granted 6 monthDescription Of Risk Free Interest Rate Share Options Granted 12 month
2023-06-304.17%
6-K · filed 2023-08-16
2022-12-316.00%
20-F · filed 2023-03-22
2022-06-306.00%
6-K/A · filed 2023-01-19
2021-12-311.30%
20-F · filed 2022-04-14